Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
14.415 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
161
Market Cap
8864.53M
P/E
34.44

Momentum Score

…

ALS Limited engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments: Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides the coal industry, such as sampling, analysis and certification, formation evaluation services, tribology testing services, and related analytical testing. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
14.41
Low
15.50
High
52 Week Price Range
13.03
Low
18.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

ALS Limited provides testing, inspection and certification services to mining, environmental, food and life‑science clients via a global laboratory and field network. Long-term growth may be supported by rising regulatory testing demand, environmental and food‑safety monitoring needs and adoption of lab automation and digital services, and the company appears positioned with diversified end-markets, recurring fee-based revenue and technical accreditations that could support more predictable cash flows.
Key risks include mining cyclicality, pricing pressure in laboratory services, acquisition execution and integration, foreign-exchange exposure and potential regulatory or quality-control incidents.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
14.41
Dividend Yield
2.74%
Revenue TTM
3320.10M
Revenue Per Share
6.60
Gross Profit TTM
995.80M
Debt / Equity
0.92
ROE
21.45%
Net Debt
1424.89M
ROCE
17.68%
Diluted EPS TTM
0.45

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 455.56M 362.70M 121.30M 390.70M 282.40M
Minority interest -2.90M -2.70M -2.10M -1.30M -1.70M
Net income 319.30M 256.20M 12.90M 291.20M 190.50M
Selling general administrative 1814.50M 1658.00M 1308.50M 1175.60M 1123.90M
Selling and marketing expenses - - 1171.30M - -
Gross profit 1039.76M 2693.50M 2194.90M 2027.00M 1880.70M
Reconciled depreciation 253.40M 233.50M 173.90M 152.40M 138.90M
Ebit 584.00M 483.50M 179.90M 434.50M 324.30M
Ebitda 837.88M 615.80M 353.80M 586.90M 463.20M
Depreciation and amortization 253.88M 132.30M 173.90M 152.40M 138.90M
Operating income 584.00M 424.50M 401.80M 434.50M 324.30M
Other operating expenses 2742.37M 2282.40M 2059.80M 1847.30M 1790.10M
Interest expense 76.44M 78.80M 58.60M 43.00M 33.30M
Tax provision 133.10M 103.80M 106.30M 114.40M 90.20M
Interest income 7.00M 10.00M 10.50M 5.40M 1.40M
Net interest income -70.20M -82.70M -57.10M -45.30M -39.00M
Income tax expense 133.35M 103.80M 106.30M 114.40M 90.20M
Total revenue 3326.37M 2999.40M 2461.60M 2279.20M 2108.50M
Total operating expenses 455.76M 2269.00M 1793.10M 1595.10M 1562.30M
Cost of revenue 2286.61M 305.90M 266.70M 252.20M 227.80M
Total other income expense net -128.44M -61.80M -520.10M 4.10M 3.00M
Discontinued operations - - - 16.20M 0.60M
Net income from continuing ops 321.60M 258.90M 15.00M 276.30M 192.20M
Net income applicable to common shares - - - 291.20M 190.50M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 3976.00M 4062.20M 3696.20M 3330.10M 2844.20M
Intangible assets 153.49M 167.30M 133.40M 113.20M 76.20M
Other current assets 86.16M 143.10M 76.70M 8.40M 19.50M
Total liab 2267.78M 2768.10M 2499.30M 1951.90M 1713.50M
Total stockholder equity 1703.01M 1279.70M 1183.30M 1366.90M 1120.10M
Other current liab 345.65M 419.10M 397.40M 332.60M 85.50M
Common stock 1704.82M 1337.40M 1325.90M 1326.10M 1321.00M
Capital stock 1701.60M 1337.40M 1325.90M 1326.10M 1321.00M
Retained earnings 68.93M -60.50M -129.40M 49.50M -76.20M
Other liab - - - 70.40M 79.60M
Good will 1459.85M 1517.40M 1376.60M 1300.70M 1118.60M
Other assets - - -44.50M 58.40M 65.50M
Cash 149.98M 268.00M 299.90M 179.60M 122.80M
Total current liabilities 672.87M 745.60M 851.50M 612.80M 738.60M
Current deferred revenue 39.78M - 0.50M - 67.20M
Net debt 1424.89M 1825.10M 1571.80M 1268.60M 1114.80M
Short term debt 117.22M 163.80M 317.70M 179.50M 342.30M
Short long term debt 28.50M 74.60M 239.60M 128.30M 299.70M
Short long term debt total 1574.87M 2093.10M 1871.70M 1448.20M 1237.60M
Other stockholder equity - - - -8.70M -124.70M
Property plant equipment - - - 812.50M 693.40M
Total current assets 987.36M 1137.30M 1028.00M 753.30M 641.90M
Long term investments 42.70M 36.60M 46.10M 293.50M 250.80M
Net tangible assets - - - -47.00M -74.70M
Short term investments - - 16.30M - 13.80M
Net receivables 624.88M 596.10M 542.90M 416.60M 386.60M
Long term debt 1190.70M 1617.50M 1235.20M 1074.30M 895.30M
Inventory 126.34M 130.10M 108.50M 101.30M 71.20M
Accounts payable 170.22M 162.70M 122.10M 100.70M 310.80M
Accumulated other comprehensive income -70.73M 2.80M -13.20M -8.70M -124.70M
Non currrent assets other 52.70M 39.60M 42.40M 32.50M 21.40M
Non current assets total 2988.64M 2924.90M 2668.20M 2576.80M 2202.30M
Capital lease obligations 352.70M 401.00M 396.90M 245.60M 342.30M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments - -327.70M -226.80M -267.00M -224.00M
Change to liabilities - - - 23.30M 50.10M
Total cashflows from investing activities -261.49M -327.70M -226.80M -267.00M -405.90M
Net borrowings -411.90M 146.70M 247.50M 55.40M 208.70M
Total cash from financing activities -339.34M -120.00M -3.10M -121.20M 77.40M
Net income 319.30M 256.20M 12.90M 291.20M 190.50M
Change in cash -93.02M -31.90M 120.30M 56.80M -45.80M
Begin period cash flow 243.00M 299.90M 179.60M 122.80M 168.60M
End period cash flow 149.98M 268.00M 299.90M 179.60M 122.80M
Total cash from operating activities 495.43M 409.60M 350.10M 439.90M 286.80M
Issuance of capital stock 367.40M - - - -
Depreciation 253.88M - 173.90M 152.50M 134.70M
Other cashflows from investing activities 1.30M 8.70M -13.90M 8.80M 1.90M
Dividends paid 193.97M 177.10M 188.80M 176.60M 131.30M
Change to inventory -4.51M -17.50M -1.80M -17.90M -6.80M
Change to account receivables -71.53M -49.00M -42.90M -40.90M -55.90M
Other cashflows from financing activities -100.79M -89.60M -61.80M 587.80M 362.60M
Change to netincome - - - 5.50M -14.10M
Capital expenditures 263.50M 165.00M 151.70M 146.10M 118.90M
Change in working capital -56.41M -66.50M -44.70M - -
Stock based compensation - - -6.40M - -
Other non cash items -21.34M 476.10M 394.80M - -
Free cash flow 231.94M 244.60M 198.40M -146.10M -118.90M

Peer Comparison*

Sector: Industrials Industry: Consulting Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CPBLF
ALS Limited
-
-%
14.41 34.44 24.04 2.67 6.45 3.62 15.62
EXPGF
Experian PLC
-
-%
37.51 26.59 19.34 4.43 6.44 4.99 14.01
EXPGY
Experian plc PK
-0.97
2.59%
36.53 26.45 19.30 4.41 6.43 4.99 14.01
VRSK
Verisk Analytics Inc
1.71
0.85%
202.23 28.72 21.88 7.52 74.89 9.06 16.91
EFX
Equifax Inc
0.72
0.41%
177.23 30.32 17.18 3.05 4.62 3.96 13.37

Profile*

ALS Limited

ALS Limited engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments: Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides the coal industry, such as sampling, analysis and certification, formation evaluation services, tribology testing services, and related analytical testing. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.

25 King Street, Brisbane, QLD, Australia, 4006

61 7 3367 7900

23342

Name Title Year Born
Mr. Raj Naran B.A., B.Sc. MD, CEO & Exec. Director 1963
Mr. Luis Damasceno Chief Financial Officer NA
Mr. Bruce McDonald BSc.Hon(Geo), M.B.A (Hons), MSc(Geology) Gen. Mang. of Geochemistry NA
Ms. Kristen Walsh Gen. Mang. of Industrial NA
Tim Kilmister Gen. Mang. of Life Sciences APAC NA
Mr. Andreas Jonsson Gen. Mang. of Life Sciences EMEA NA
Mr. Michael Paul Pearson ACIS, BA, GAICD, L.L.B., LLB Gen. Counsel & Company Sec. NA
Ms. Susan Putters B Bus (Strategic Human resources management), MBA Global Head of HR NA
Mr. Michael Burcham B Sc, GradDip Env, Grad Cert RM,Grad Dip App, MRAC Chief Risk Officer NA
Mr. Greg Affleck B. Bus (Accounting), CPA Group Financial Controller NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…